Despite the clear evidence showing the Lgr5‐dependent role in the siRNA assay and the enhanced sensitive to RSPO stimulation in vivo, it is admittedly difficult to dissect whether the enhanced stem cell and tumour phenotypes in the mutant intestine are caused by Lgr5 or Dvl2 or both. Here, LGR5 is linked to neoplasm.